Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide. 2017

Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.

Opiates are potent analgesics but their clinical use is limited by side effects including analgesic tolerance and opioid-induced hyperalgesia (OIH). The Opiates produce analgesia and other adverse effects through activation of the mu opioid receptor (MOR) encoded by the Oprm1 gene. However, MOR and morphine metabolism involvement in OIH have been little explored. Hence, we examined MOR contribution to OIH by comparing morphine-induced hyperalgesia in wild type (WT) and MOR knockout (KO) mice. We found that repeated morphine administration led to analgesic tolerance and hyperalgesia in WT mice but not in MOR KO mice. The absence of OIH in MOR KO mice was found in both sexes, in two KO global mutant lines, and for mechanical, heat and cold pain modalities. In addition, the morphine metabolite morphine-3beta-D-glucuronide (M3G) elicited hyperalgesia in WT but not in MOR KO animals, as well as in both MOR flox and MOR-Nav1.8 sensory neuron conditional KO mice. M3G displayed significant binding to MOR and G-protein activation when using membranes from MOR-transfected cells or WT mice but not from MOR KO mice. Collectively our results show that MOR is involved in hyperalgesia induced by chronic morphine and its metabolite M3G.

UI MeSH Term Description Entries
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009022 Morphine Derivatives Analogs or derivatives of morphine. Morphines
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006930 Hyperalgesia An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve. Hyperalgesia, Tactile,Hyperalgesia, Thermal,Hyperalgia,Hyperalgia, Mechanical,Hyperalgia, Primary,Hyperalgia, Secondary,Allodynia,Allodynia, Mechanical,Allodynia, Tactile,Allodynia, Thermal,Hyperalgesia, Mechanical,Hyperalgesia, Primary,Hyperalgesia, Secondary,Hyperalgesic Sensations,Mechanical Allodynia,Mechanical Hyperalgesia,Tactile Allodynia,Thermal Allodynia,Allodynias,Hyperalgesias,Hyperalgesias, Thermal,Hyperalgesic Sensation,Mechanical Hyperalgia,Mechanical Hyperalgias,Primary Hyperalgia,Primary Hyperalgias,Secondary Hyperalgia,Secondary Hyperalgias,Sensation, Hyperalgesic,Sensations, Hyperalgesic,Thermal Hyperalgesia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors

Related Publications

Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
December 2012, Molecular medicine (Cambridge, Mass.),
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
May 2012, European journal of pharmacology,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
November 2001, Biochemical pharmacology,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
January 2016, Pharmacology, biochemistry, and behavior,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
January 1998, Pharmacology & toxicology,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
June 1988, Brain research,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
October 2005, Molecular pharmacology,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
August 2003, Anesthesia and analgesia,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
March 2018, Journal of analytical toxicology,
Laurie-Anne Roeckel, and Valérie Utard, and David Reiss, and Jinane Mouheiche, and Hervé Maurin, and Anne Robé, and Emilie Audouard, and John N Wood, and Yannick Goumon, and Frédéric Simonin, and Claire Gaveriaux-Ruff
March 2007, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!